Necrobiotic xanthogranuloma: response to dapsone.

Dermatol Ther

Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Published: September 2015

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12179DOI Listing

Publication Analysis

Top Keywords

necrobiotic xanthogranuloma
4
xanthogranuloma response
4
response dapsone
4
necrobiotic
1
response
1
dapsone
1

Similar Publications

Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment.

Am J Ophthalmol Case Rep

March 2025

Ophthalmic Surgeons and Consultants of Ohio, Columbus, OH, USA.

Purpose: To describe a case report of the successful management of necrobiotic xanthogranuloma (NXG), a rare periorbital disease.

Observations: A 61-year-old patient presented with bilateral upper and lower lid lesions which were initially misdiagnosed as xanthelasmas and later confirmed to be NXG. Further investigation also uncovered a diagnosis of multiple myeloma.

View Article and Find Full Text PDF

Foamy Cell Angiosarcoma Resembling a Xanthomatous Histiocytic Infiltrate Without Evidence of Vascular Malignancy.

J Cutan Pathol

December 2024

Department of Medicine, Division of Dermatology, St. Louis School of Medicine, Washington University, St. Louis, Missouri, USA.

Angiosarcoma is a rare and aggressive malignancy of endothelial cells with multiple subtypes. Foamy cell angiosarcoma is a rare variant in which endothelial cells demonstrate "foamy" cytoplasmic change. We present the case of a 59-year-old male who presented with progressive erythema and swelling of the midface and bilateral eyelids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!